Oxidative Stress: Dual Pathway Induction in Cardiorenal Syndrome Type 1 Pathogenesis

Abstract EN

Cardiorenal Syndrome Type 1 (Type 1) is a specific condition which is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI).

Even though its pathophysiology is complex and not still completely understood, oxidative stress seems to play a pivotal role.

In this study, we examined the putative role of oxidative stress in the pathogenesis of CRS Type 1.

Twenty-three patients with acute heart failure (AHF) were included in the study.

Subsequently, 11 patients who developed AKI due to AHF were classified as CRS Type 1.

Quantitative determinations for IL-6, myeloperoxidase (MPO), nitric oxide (NO), copper/zinc superoxide dismutase (Cu/ZnSOD), and endogenous peroxidase activity (EPA) were performed.

CRS Type 1 patients displayed significant augmentation in circulating ROS and RNS, as well as expression of IL-6.

Quantitative analysis of all oxidative stress markers showed significantly lower oxidative stress levels in controls and AHF compared to CRS Type 1 patients ( P < 0.05 ).

This pilot study demonstrates the significantly heightened presence of dual oxidative stress pathway induction in CRS Type 1 compared to AHF patients.

Our findings indicate that oxidative stress is a potential therapeutic target, as it promotes inflammation by ROS/RNS-linked pathogenesis.